Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuyoshi Sato

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Nagoya Journal of Medical Science|October 14, 2022
Black ascitesYasuyoshi Sato, Naomi Hayashi, Shunji Takahashi
Oncotargets and Therapy|December 10, 2015
Cetuximab could be more effective without prior bevacizumab treatment in metastatic colorectal cancer patientsYasuyoshi Sato, Satoshi Matsusaka, Mitsukuni Suenaga, et al.
Anticancer Research|June 26, 2024
Ramucirumab Beyond Disease Progression After Paclitaxel Plus Ramucirumab in Gastric Cancer: A Phase II TrialYasuyoshi Sato, Hiroharu Yamashita, Koichi Yagi, et al.
Japanese Journal of Clinical Oncology|September 25, 2023
Squamous cell carcinoma of the eyelidYasuyoshi Sato, Shunji Takahashi, Takashi Toshiyasu, et al.
Cancer Cell|January 19, 2021
Changes in Treatment Behavior during the COVID-19 Pandemic among Patients at a Cancer HospitalYasuyoshi Sato, Yu Fujiwara, Naoki Fukuda, et al.
Biochemistry and Biophysics Reports|November 17, 2021
Two distinct phenotypes of immunologically hot gastric cancer subtypesNoriyuki Saito, Yukari Kobayashi, Koji Nagaoka, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 3, 2023
Low pretherapy skeletal muscle mass index is associated with an increased risk of febrile neutropenia in patients with esophageal cancer receiving docetaxel + cisplatin + 5-fluorouracil (DCF) therapyKatsuhiko Nara, Takehito Yamamoto, Yasuyoshi Sato, et al.
The American Journal of Surgical Pathology|July 26, 2021
Human Leukocyte Antigen Class I Deficiency in Gastric Carcinoma: An Adaptive Immune Evasion Strategy Most Common in Microsatellite Instable TumorsAkiko Iwasaki, Aya Shinozaki-Ushiku, Akiko Kunita, et al.
Cytotherapy|March 30, 2021
Adoptive γδT-cell transfer alone or combined with chemotherapy for the treatment of advanced esophageal cancerYasuyoshi Sato, Kazuhiko Mori, Kosuke Hirano, et al.
Scientific Reports|May 20, 2022
Selection of RNA-based evaluation methods for tumor microenvironment by comparing with histochemical and flow cytometric analyses in gastric cancerNoriyuki Saito, Yasuyoshi Sato, Hiroyuki Abe, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Nagoya Journal of Medical Science|October 14, 2022
Black ascitesYasuyoshi Sato, Naomi Hayashi, Shunji Takahashi
Oncotargets and Therapy|December 10, 2015
Cetuximab could be more effective without prior bevacizumab treatment in metastatic colorectal cancer patientsYasuyoshi Sato, Satoshi Matsusaka, Mitsukuni Suenaga, et al.
Anticancer Research|June 26, 2024
Ramucirumab Beyond Disease Progression After Paclitaxel Plus Ramucirumab in Gastric Cancer: A Phase II TrialYasuyoshi Sato, Hiroharu Yamashita, Koichi Yagi, et al.
Japanese Journal of Clinical Oncology|September 25, 2023
Squamous cell carcinoma of the eyelidYasuyoshi Sato, Shunji Takahashi, Takashi Toshiyasu, et al.
Cancer Cell|January 19, 2021
Changes in Treatment Behavior during the COVID-19 Pandemic among Patients at a Cancer HospitalYasuyoshi Sato, Yu Fujiwara, Naoki Fukuda, et al.
Biochemistry and Biophysics Reports|November 17, 2021
Two distinct phenotypes of immunologically hot gastric cancer subtypesNoriyuki Saito, Yukari Kobayashi, Koji Nagaoka, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 3, 2023
Low pretherapy skeletal muscle mass index is associated with an increased risk of febrile neutropenia in patients with esophageal cancer receiving docetaxel + cisplatin + 5-fluorouracil (DCF) therapyKatsuhiko Nara, Takehito Yamamoto, Yasuyoshi Sato, et al.
The American Journal of Surgical Pathology|July 26, 2021
Human Leukocyte Antigen Class I Deficiency in Gastric Carcinoma: An Adaptive Immune Evasion Strategy Most Common in Microsatellite Instable TumorsAkiko Iwasaki, Aya Shinozaki-Ushiku, Akiko Kunita, et al.
Cytotherapy|March 30, 2021
Adoptive γδT-cell transfer alone or combined with chemotherapy for the treatment of advanced esophageal cancerYasuyoshi Sato, Kazuhiko Mori, Kosuke Hirano, et al.
Scientific Reports|May 20, 2022
Selection of RNA-based evaluation methods for tumor microenvironment by comparing with histochemical and flow cytometric analyses in gastric cancerNoriyuki Saito, Yasuyoshi Sato, Hiroyuki Abe, et al.
Pageof 6